Merz Therapeutics
NC - RaleighBiotechnology
Focus: Merz Therapeutics is a specialty biotech focused on small molecule therapeutics in neurology, metabolic diseases, cardiovascular, and infectious disease indications. The company operates from Raleigh, NC with a revenue base heavily concentrated in legacy neurological products.
Profile data last refreshed Yesterday · AI intelligence enriched 2w ago
Open Jobs
0
About Merz Therapeutics
AI assessmentNot HiringNo open roles listed right now. Follow Merz Therapeutics to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
3/9 — Basic
Company HealthStrong
Pipeline
Mid-stage
2 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Key Products
$44M Part DDeclining
LOE Approaching
Flagship revenue driver (59% of revenue) with approaching loss of exclusivity, creating critical cash flow risk.
Help build intelligence for Merz Therapeutics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.